UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000009519
Receipt No. R000010712
Scientific Title Comparison study among FM/BUD(Formoterol/Budesonide), SM/FP (Salmeterol/Fluticasone), SB(Salbutamol) about bronchodilating effect part and onset of relief of dyspnea.
Date of disclosure of the study information 2013/01/01
Last modified on 2020/06/26 (Ver. 9)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Comparison study among FM/BUD(Formoterol/Budesonide), SM/FP (Salmeterol/Fluticasone), SB(Salbutamol) about bronchodilating effect part and onset of relief of dyspnea.
Acronym Comparison study among FM/BUD(Formoterol/Budesonide), SM/FP (Salmeterol/Fluticasone), SB(salbutamol)about bronchodilating effect part and onset of relief of dyspnea.
Scientific Title Comparison study among FM/BUD(Formoterol/Budesonide), SM/FP (Salmeterol/Fluticasone), SB(Salbutamol) about bronchodilating effect part and onset of relief of dyspnea.
Scientific Title:Acronym Comparison study among FM/BUD(Formoterol/Budesonide), SM/FP (Salmeterol/Fluticasone), SB(salbutamol)about bronchodilating effect part and onset of relief of dyspnea.
Region
Japan

Condition
Condition Adults who were induced bronchoconstriction by methacholine.
Classification by specialty
Pneumology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To compare bronchodilating effect among FM/BUD, SM/FP, SB.
Basic objectives2 Pharmacodynamics
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Respiratory impedance, Borg scale
Key secondary outcomes FEV1.0, Lung capacity

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 4
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Formoterol/Budesonide
Interventions/Control_2 Salmeterol/Fluticasone
Interventions/Control_3 Salbutamol
Interventions/Control_4 Control(No treatment)
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
40 years-old >=
Gender Male and Female
Key inclusion criteria 1.Male or female aged between 20 and 40 years.
2.The forced expiratory volume in one second has to at least 70 percent of predicted value.
Key exclusion criteria 1.Aortic aneurysm
2.Pregnancy
3.History of cerebral infarction within three months.
4.Breast-feeding women
5.Hypertension
6.Diabetes mellitus
7.Hyperthyroidism
8.Cardiac disease
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Ryo
Middle name
Last name Atsuta
Organization Juntendo University
Division name Respiratory Medicine
Zip code 1138421
Address 3-1-1, Hongo, Bunkyo-ku, Tokyo, Japan
TEL 0358021063
Email atsuta@juntendo.ac.jp

Public contact
Name of contact person
1st name Yukinari
Middle name
Last name Itoigawa
Organization 1978
Division name Respiratory Medicine
Zip code 3300062
Address 3-1-1, Hongo, Bunkyo-ku, Tokyo, Japan
TEL 03-5802-1063
Homepage URL
Email yuitoiga@gmail.com

Sponsor
Institute Juntendo University
Institute
Department

Funding Source
Organization Juntendo University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Juntendo University
Address 3-1-1, Hongo, Bunkyo-ku, Tokyo, Japan
Tel 03-5802-1584
Email kenkyu5858@juntendo.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 01 Month 01 Day

Related information
URL releasing protocol N/A
Publication of results Unpublished

Result
URL related to results and publications N/A
Number of participants that the trial has enrolled 11
Results
N/A
Results date posted
2020 Year 06 Month 26 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
N/A
Participant flow
N/A
Adverse events
N/A
Outcome measures
N/A
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 01 Month 01 Day
Date of IRB
2012 Year 07 Month 27 Day
Anticipated trial start date
2012 Year 07 Month 27 Day
Last follow-up date
2013 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information N/A

Management information
Registered date
2012 Year 12 Month 11 Day
Last modified on
2020 Year 06 Month 26 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000010712